Zobrazeno 1 - 10
of 101
pro vyhledávání: '"Peninnah Oberdorfer"'
Autor:
Wasan Katip, Ajaree Rayanakorn, Peninnah Oberdorfer, Puntapong Taruangsri, Teerapong Nampuan, Siriporn Okonogi
Publikováno v:
Journal of Infection and Public Health, Vol 17, Iss 5, Pp 727-734 (2024)
Background: Carbapenem-resistant Enterobacteriaceae (CRE) infections pose a significant threat to global health due to limited treatment options and high mortality rates. Colistin-based regimens have emerged as a primary treatment approach, but the e
Externí odkaz:
https://doaj.org/article/8b29409a72ce40e9bd50ecb1d38c92ee
Publikováno v:
Pharmaceutical Sciences, Vol 30, Iss 2, Pp 244-251 (2024)
Background: Colistin use is primarily associated with nephrotoxicity, which has been shown to be reversible with a low incidence of long-term kidney impairment. This study aimed to investigate the risk factors for acute kidney injury (AKI) in patient
Externí odkaz:
https://doaj.org/article/9100ef814a934131bb12f470db0fc4cd
Publikováno v:
Journal of Infection and Public Health, Vol 16, Iss 8, Pp 1249-1255 (2023)
Background: Carbapenem-resistant Acinetobacter baumannii (CRAB) is one of the most commonly found nosocomial infections in critically ill patients. However, the appropriate treatment period for a specific group of critically ill patients with CRAB in
Externí odkaz:
https://doaj.org/article/ed1b128509694e2aa62c82a32ff31c1f
Autor:
Wasan Katip, Ajaree Rayanakorn, Chuleegone Sornsuvit, Purida Wientong, Peninnah Oberdorfer, Puntapong Taruangsri, Teerapong Nampuan
Publikováno v:
Antibiotics, Vol 13, Iss 3, p 287 (2024)
Carbapenem-resistant Acinetobacter baumannii (CRAB) infections pose a serious threat, with high morbidity and mortality rates. This retrospective cohort study, conducted at Nakornping Hospital between January 2015 and October 2022, aimed to evaluate
Externí odkaz:
https://doaj.org/article/32e8a62c218d460d98af754a52bbe100
Publikováno v:
Vaccines, Vol 11, Iss 9, p 1458 (2023)
Background: The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic has outpaced vaccine availability and delivery from vaccine manufacturers, and thus, a scarcity of vaccines happened to many countries around the world. In Thailand
Externí odkaz:
https://doaj.org/article/0f7dbdc4c1554d41a0a83cc79b9bb9d4
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-8 (2021)
Abstract Colistin provides in vitro activity against numerous ESBL-producing and carbapenem-resistant bacteria. However, clinical information with respect to its utilization in infection caused by ESBL producers is limited. The aim of this study was
Externí odkaz:
https://doaj.org/article/bc40a2bfda11409a86911ed0670b7c36
Publikováno v:
Frontiers in Pharmacology, Vol 12 (2022)
The objective of this study was to evaluate the relationship between vancomycin trough levels in patients with documented enterococcal infections and mortality, clinical outcomes, microbiological outcomes, and nephrotoxicity. We conducted a retrospec
Externí odkaz:
https://doaj.org/article/33dd6cf35850463da2e631c00a429184
Publikováno v:
International Journal of Infectious Diseases, Vol 97, Iss , Pp 391-395 (2020)
Introduction: Acinetobacter baumannii has emerged as an important nosocomial pathogen worldwide. In Thailand, the incidence and mortality rate of carbapenem-resistant A. baumannii (CRAB) is continuously increasing. This organism is a common pathogen
Externí odkaz:
https://doaj.org/article/35c55842579d43d5afe1b9e2087ef65c
Publikováno v:
International Journal of Infectious Diseases, Vol 92, Iss , Pp 151-159 (2020)
Background: Vancomycin is a common drug used in children with severe infection. In adults, at least 15 mg/L of the optimal vancomycin trough concentration (Ctrough) is needed to generate the target 24-h area under the concentration-time curve (AUC24)
Externí odkaz:
https://doaj.org/article/96869092a8c54049a6b3eb7dc8f14c5e
Publikováno v:
Pharmaceutics, Vol 14, Iss 6, p 1266 (2022)
Carbapenem-resistant Acinetobacter baumannii (CRAB) is becoming more widely recognized as a serious cause of nosocomial infections, and colistin has been reintroduced in recent years for the treatment of CRAB infection. Combinations of colistin and m
Externí odkaz:
https://doaj.org/article/08251ad912ac492db38f5ffc8655e717